^Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS (februar 1992). „A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini”. J. Biol. Chem. 267 (5): 3257—61. PMID1339448. doi:10.1016/S0021-9258(19)50724-4.CS1 održavanje: Format datuma (veza)
^Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Bélanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Louisot P, Magdalou J, Chowdhury JR, Ritter JK, Schachter H, Tephly TR, Tipton KF, Nebert DW (avgust 1997). „The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence”. Pharmacogenetics. 7 (4): 255—69. PMID9295054. doi:10.1097/00008571-199708000-00001.CS1 održavanje: Format datuma (veza)
Yea SS, Lee SS, Kim WY, et al. (2008). „Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population.”. Ther Drug Monit. 30 (1): 23—34. PMID18223459. S2CID34396409. doi:10.1097/FTD.0b013e3181633824.
van Es HH, Bout A, Liu J, et al. (1993). „Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37”. Cytogenet. Cell Genet. 63 (2): 114—6. PMID8467709. doi:10.1159/000133513.
Gong QH, Cho JW, Huang T, et al. (2001). „Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus”. Pharmacogenetics. 11 (4): 357—68. PMID11434514. doi:10.1097/00008571-200106000-00011.
Ross CJ, Katzov-Eckert H, Dubé MP, et al. (2009). „Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy”. Nat. Genet. 41 (12): 1345—9. PMID19898482. S2CID21293339. doi:10.1038/ng.478.